- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Glenmark Pharma's US arm to launch Eribulin Mesylate injection in the US market | 2 | capitalmarket.com | ||
| 20.08. | Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter | 5 | FiercePharma | ||
| 19.08. | Glenmark Pharma's US arm to launch Micafungin injection in the US market | 2 | capitalmarket.com | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 18.08. | Glenmark Pharma shares tumble despite market-wide rally post-Q1 results | 2 | ZEE Business | ||
| 18.08. | Glenmark Pharma, HDFC Bank among 10 stocks that showed RSI Trending Up on August 14 | 3 | Times of India | ||
| 06.08. | Glenmark Pharmaceuticals Subsidiary Reaches $37.75 Million Settlement in US Antitrust Case | 3 | CPI | ||
| 28.07. | Glenmark Pharmaceuticals Ltd spurts 1.22%, up for third straight session | 3 | capitalmarket.com | ||
| 18.07. | Glenmark stock downgraded to Sell by ICICI Securities despite price target hike | 6 | Investing.com | ||
| 18.07. | ICICI Securities stuft Glenmark-Aktie trotz Kurszielerhöhung auf 'Verkaufen' herab | 3 | Investing.com Deutsch | ||
| 16.07. | Glenmark Pharmaceuticals Ltd up for five straight sessions | 2 | capitalmarket.com | ||
| 14.07. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 2 | capitalmarket.com | ||
| 14.07. | Glenmark Pharma receives warning letter from USFDA for Indore facility | 2 | capitalmarket.com | ||
| 13.07. | Breakout Stocks: How to trade Glenmark Pharma, Jaiprakash Power Ventures & EID Parry that hit fresh 52-week high? | 3 | Times of India | ||
| 11.07. | Glenmark Pharma among 8 stocks that hit 52-week highs, rally up to 35% in a month | 2 | Times of India | ||
| 11.07. | Gainers & Losers: Glenmark Pharma, BSE among 7 stocks that hogged the limelight today | 2 | Times of India | ||
| 11.07. | Glenmark Pharma hits record high after $2B licensing deal for cancer drug | 2 | iNVEZZ.com | ||
| 11.07. | Shares Of Glenmark Pharmaceuticals Jump 10% After Deal With AbbVie; USD 2 Billion To Commercialise Cancer & Autoimmune Diseases Healing Drug | 4 | The Free Press Journal | ||
| 11.07. | Mid-day Trade: Sensex falls 648 points, Nifty below 25,200 as TCS drags IT; Glenmark hits 10% upper circuit | 2 | ZEE Business | ||
| 11.07. | Glenmark Pharma soars on AbbVie licensing deal for cancer therapy ISB 2001 | 3 | capitalmarket.com | ||
| 11.07. | Glenmark Pharmaceuticals Ltd leads gainers in 'A' group | 2 | capitalmarket.com |
1 2 3 4 Weiter >>
67 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,055 | +0,05 % | SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE SIX MONTHS ENDED 30 JUNE 2025 | ||
| CSPC PHARMA | 1,170 | -2,05 % | CSPC PHARMA (01093): NEXT DAY DISCLOSURE RETURNS | ||
| WUXI BIOLOGICS | 3,978 | -0,19 % | WuXi Biologics-Aktie: Kurs klettert leicht (3,656 €) | Im Wertpapierhandel liegt die Aktie von WuXi Biologics gegenwärtig im Plus. Die Aktie notiert zur Stunde bei 3,66 Euro. An der Börse liegt die WuXi Biologics-Aktie aktuell im Plus. Das Wertpapier legte... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,540 | 0,00 % | Fosun Pharma Announces 2025 Interim Results | Enhancing Innovation Efficiency and Steadily Expanding Globally
SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- On August 26, 2025, Shanghai Fosun Pharmaceutical (Group)... ► Artikel lesen | |
| GEDEON RICHTER | 26,400 | +2,09 % | Richter to Market USYMRO Biosimilar Following EC Approval | ||
| DR REDDYS | 12,000 | +0,84 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| ASPEN PHARMACARE | 5,000 | -1,96 % | ASPEN PHARMACARE HOLDINGS LIMITED - Business Update and Trading Statement for the Financial year ended 30 June 2025 | ||
| SHANGHAI PHARMACEUTICALS | 1,320 | -2,94 % | SH PHARMA (02607): ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025 | ||
| LUYE PHARMA | 0,418 | +3,47 % | LUYE PHARMA (02186): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,161 | -1,83 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,525 | 0,00 % | Dividendenbekanntmachungen (28.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABO ENERGY GMBH & CO KGAA DE0005760029 - 0,65 EUR AIA GROUP LTD HK0000069689 1,3098 HKD 0,1474 EUR ALLIANZ SE ADR US0188201000 1... ► Artikel lesen | |
| HANSOH PHARMACEUTICAL | 4,000 | 0,00 % | HANSOH PHARMA (03692): VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE SECOND INDICATION OF XINYUE (INEBILIZUMAB INJECTION) WAS GRANTED BY ... | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,935 | -0,53 % | SHINEWAY PHARM Leaps 4%+ Despite 1.9% Drop in Interim NP; DPS Unchanged | ||
| KALBE FARMA | 0,056 | +6,67 % | KLBF schedules IDR 250 billion buyback starting 4 September: KLBF to repurchase shares (buyback) worth IDR 250 ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE ... |
Das Unternehmen GLENMARK PHARMACEUTICALS LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.